Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-03-09 11:20 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
26,750 | |
Filed 2021-12-29 17:07 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,807 vol |
||
Filed 2021-12-29 17:08 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,807 vol |
47,190 | |
Filed 2021-12-29 17:07 Tx date 2021-12-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,807 vol |
37,693 | |
Filed 2020-12-23 12:21 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,544 vol |
31,383 | |
Filed 2020-12-23 12:20 Tx date 2020-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,750 vol |
53,500 | |
Filed 2020-02-03 17:25 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$158.39
+15,839 vol $0.01 each |
15,839 | |
Filed 2020-02-03 17:25 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-02-03 17:24 Tx date 2019-12-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-267.50
-26,750 vol $0.01 each |
80,250 | |
Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
||
Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
Filed 2018-12-27 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-27 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Poncy, William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 |